Bloomberg Podcasts
@bloombergpodcasts·503K subscribers·32.4K videos
Microsoft and Meta Surge; Eli Lilly Slides; Harley Davidson and Tariffs | Stock Movers
Posted
May 1, 2025
Views
164
Likes
2
Engagement
1.22%
May 1, 2025
164
2
1.22%
Every word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
See what was published immediately before and after this episode.
4:05Now PlayingOn this episode of Stock Movers:
- Microsoft (MSFT) shares are higher this morning after an earnings blowout. The company reported stronger-than-expected quarterly sales and profit growth as the Azure cloud unit posted a 33% revenue gain in the quarter, beating the Wall Street estimate of 29%. It suggests customer demand for cloud services has held steady despite a wave of tariffs and economic turbulence. The world’s largest software maker is considered a leader in commercializing AI products, thanks to its close partnership with ChatGPT maker OpenAI. In addition to providing computing infrastructure, Microsoft has launched AI assistants in widely used productivity applications such as Office and Excel.
- Meta (META) shares, along with Microsoft, are helping lead the Mag 7 higher after the company reported $42.3 billion in first-quarter sales, beating analysts' estimates of $41.4 billion. Meta expects to spend $64 billion to $72 billion this year, up from its prior outlook, due to tariffs imposed by the Trump administration and investments in artificial intelligence. Meta's advertising business, which makes up 98% of the company's revenue, is growing, and the company is investing heavily in AI development, including a new standalone AI app, to compete with rivals.
- Eli Lilly (LLY) dropped in the premarket after the drugmaker cut its adjusted earnings per share forecast for the full year. The company also reported first-quarter sales of its blockbuster weight-loss drug, Zepbound, that was in line with expectations. It also follows CVS' drug-benefits unit negotiated a deal to make Novo Nordisk A/S's Wegovy more widely available to its members, replacing Zepbound.
- Harley Davidson (HOG) shares are lower after pulling its 2025 financial outlook, citing the “tariff situation” and macroeconomic conditions. It also reported revenue for the first quarter that missed the average analyst estimate.
See omnystudio.com/listener () for privacy information.
Bloomberg journalists discuss today's biggest winners and losers in the stock market. Listen for analysis on the companies making news on Wall Street.
Check out more episodes of Stock Movers
Follow Bloomberg Podcasts on Twitter
Visit our other YouTube channels:
Bloomberg Television
Bloomberg Originals
For coverage on news, markets and more
#Stocks #Markets #Finance #Investing #Podcast #Bloomberg
Microsoft and Meta Surge; Eli Lilly Slides; Harley Davidson and Tariffs
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.
